The Effect and Safety of Pulsed Field Ablation (PFA) in Patients With Paroxysmal Atrial Fibrillation (PAF)
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 144 participants.
Also called NCT05400928
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 144 participants
- Sponsor
- Registry
-
NCT05400928
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05400928. Allocation not applicable; no masking; primary purpose treatment. Start 2021-07-05 (actual); primary completion 2022-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect and Safety of Pulsed Field Ablation (PFA) in Patients With Paroxysmal Atrial Fibrillation (PAF)
- Acronym
- ESPFA-CN21
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- Pulsed Field Ablation
- Lead sponsor
- Tongji Hospital
- Collaborator
- Jiangxi Provincial People's Hopital
- Collaborator
- Second Affiliated Hospital of Guangzhou Medical University
- Collaborator
- Central South University
- Collaborator
- Second Affiliated Hospital of Nanchang University
- Collaborator
- Zhongshan Hospital Xiamen University
- Collaborator
- The First Affiliated Hospital of Dalian Medical University
- Collaborator
- Chinese Academy of Medical Sciences, Fuwai Hospital
Record details
- Record id
cardio:ct-nct05400928- Content hash
0a987ad476620903ef7d66379bc46e1d4a2cf02a22a4f7d501af4fbd221290e0